These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30745146)

  • 21. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Robison SG; Thomas AR
    Vaccine; 2018 Oct; 36(45):6683-6687. PubMed ID: 30287157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.
    Ridenhour BJ; Campitelli MA; Kwong JC; Rosella LC; Armstrong BG; Mangtani P; Calzavara AJ; Shay DK
    PLoS One; 2013; 8(10):e76318. PubMed ID: 24146855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.
    Izurieta HS; Thadani N; Shay DK; Lu Y; Maurer A; Foppa IM; Franks R; Pratt D; Forshee RA; MaCurdy T; Worrall C; Howery AE; Kelman J
    Lancet Infect Dis; 2015 Mar; 15(3):293-300. PubMed ID: 25672568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
    Pelton SI; Divino V; Postma MJ; Shah D; Mould-Quevedo J; DeKoven M; Krishnarajah G
    Vaccine; 2021 Apr; 39(17):2396-2407. PubMed ID: 33810903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative vaccine efficacy of high-dose versus standard-dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population.
    Paudel M; Mahmud S; Buikema A; Korrer S; Van Voorhis D; Brekke L; Chit A
    Vaccine; 2020 Jun; 38(29):4548-4556. PubMed ID: 32446835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of influenza vaccination on healthcare utilization - A systematic review.
    Doyon-Plourde P; Fakih I; Tadount F; Fortin É; Quach C
    Vaccine; 2019 May; 37(24):3179-3189. PubMed ID: 31047677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
    Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults.
    Palmu AA; Pepin S; Syrjänen RK; Mari K; Mallett Moore T; Jokinen J; Nieminen H; Kilpi T; Samson SI; De Bruijn I
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13270. PubMed ID: 38569647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.
    Butler AM; Layton JB; Dharnidharka VR; Sahrmann JM; Seamans MJ; Weber DJ; McGrath LJ
    Am J Kidney Dis; 2020 Jan; 75(1):72-83. PubMed ID: 31378646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season.
    Izurieta HS; Lu M; Kelman J; Lu Y; Lindaas A; Loc J; Pratt D; Wei Y; Chillarige Y; Wernecke M; MaCurdy TE; Forshee R
    Clin Infect Dis; 2021 Dec; 73(11):e4251-e4259. PubMed ID: 33211809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial.
    Lassen MCH; Johansen ND; Modin D; Nealon J; Samson S; Dufournet M; Loiacono MM; Larsen CS; Jensen AMR; Landler NE; Claggett BL; Solomon SD; Landray MJ; Gislason GH; Køber L; Jensen JUS; Sivapalan P; Vestergaard LS; Krause TG; Biering-Sørensen T
    Diabetes Obes Metab; 2024 May; 26(5):1821-1829. PubMed ID: 38586966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design.
    Zimmerman RK; Patricia Nowalk M; Dauer K; Clarke L; Raviotta JM; Balasubramani GK
    Vaccine; 2023 Aug; 41(35):5134-5140. PubMed ID: 37474406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
    Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
    JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Thompson MG; Pierse N; Sue Huang Q; Prasad N; Duque J; Claire Newbern E; Baker MG; Turner N; McArthur C;
    Vaccine; 2018 Sep; 36(39):5916-5925. PubMed ID: 30077480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons.
    Levin MJ; Divino V; Postma MJ; Pelton SI; Zhou Z; DeKoven M; Mould-Quevedo J
    Expert Rev Vaccines; 2024; 23(1):124-136. PubMed ID: 38073493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).
    Nichols MK; Andrew MK; Hatchette TF; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Lagacé-Wiens P; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Powis J; Richardson D; Schuind A; Semret M; Shinde V; Smith S; Smyth D; Stiver G; Taylor G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    Vaccine; 2018 Apr; 36(16):2166-2175. PubMed ID: 29548608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of influenza vaccine in reducing influenza-associated hospitalizations and deaths among the elderly population; Lazio region, Italy, season 2016-2017.
    Fabiani M; Volpe E; Faraone M; Bella A; Pezzotti P; Chini F
    Expert Rev Vaccines; 2020 May; 19(5):479-489. PubMed ID: 32237925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older.
    Baxter R; Ray GT; Fireman BH
    Vaccine; 2010 Oct; 28(45):7267-72. PubMed ID: 20832494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly.
    Lapi F; Marconi E; Simonetti M; Baldo V; Rossi A; Sessa A; Cricelli C
    Expert Rev Vaccines; 2019 Jun; 18(6):663-670. PubMed ID: 31155968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.